Načítá se...
Treatment for severe COVID-19 with a biomimetic sorbent haemoperfusion device in patients on haemodialysis
Haemodialysis (HD) patients present more morbidity and mortality risk in coronavirus disease 2019 (COVID-19). In patients who may develop severe symptoms, the process called ‘viral sepsis’ seems to be a crucial mechanism. In those cases, the HD procedure provides an excellent tool to explore the ben...
Uloženo v:
| Vydáno v: | Clin Kidney J |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7929023/ https://ncbi.nlm.nih.gov/pubmed/33953913 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfab010 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|